Related Experiment Video
Updated: Jul 4, 2026

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
Die hard: when cells refuse apoptosis-the rise of paraptosis and other death pathways
Cecilia Anceschi1, Elena Frediani1, Jessica Ruzzolini1
1Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
Abstract:
Resistance to apoptosis remains a major barrier in cancer therapy, driving interest in alternative regulated cell death (RCD) programs. Paraptosis, a caspase-independent RCD marked by cytoplasmic vacuolization, ER dilation, and mitochondrial swelling, emerges as a promising vulnerability in apoptosis-refractory tumors. Its therapeutic potential has been limited by incomplete understanding of its dynamic regulation within heterogeneous tumor ecosystems. In this review, we introduce paraptotic plasticity, describing cancer cells' ability to reversibly switch between paraptosis-sensitive and -resistant states in response to metabolic stress, therapeutic pressure, and tumor microenvironmental cues. This plasticity reveals a previously unrecognized mechanism of therapeutic resistance and uncovers exploitable vulnerabilities for precision targeting. We outline key molecular determinants, including ER stress, mitochondrial dysfunction, ion homeostasis, and proteotoxic stress, and highlight the emerging influence of microbiota-derived metabolites in shaping paraptotic outcomes. Finally, we discuss nanotechnology-enabled strategies that leverage these vulnerabilities, offering a translational roadmap to overcome resistance in hard-to-treat cancers.
Insights
Cancer cells can switch between paraptosis-sensitive and -resistant states, a plasticity that drives therapeutic resistance. Understanding this regulated cell death (RCD) mechanism offers new precision targeting strategies for difficult-to-treat cancers.
Area of Science:
- Oncology
- Cell Biology
- Cancer Therapeutics
Background:
- Resistance to apoptosis is a significant challenge in cancer treatment.
- Paraptosis, a form of regulated cell death (RCD), presents a potential therapeutic vulnerability in apoptosis-refractory tumors.
- Limited understanding of paraptosis regulation within tumor ecosystems hinders its therapeutic application.
Purpose of the Study:
- To introduce the concept of paraptotic plasticity in cancer cells.
- To explore the molecular mechanisms and environmental factors influencing paraptotic plasticity.
- To discuss potential therapeutic strategies, including nanotechnology, to exploit paraptotic vulnerabilities.
Main Methods:
- Review of existing literature on paraptosis, apoptosis resistance, and tumor microenvironment.
- Analysis of molecular determinants of paraptosis, including ER stress, mitochondrial function, and proteotoxic stress.
- Discussion of the role of microbiota-derived metabolites and nanotechnology in modulating paraptosis.
Main Results:
- Cancer cells exhibit "paraptotic plasticity," reversibly switching between sensitivity and resistance to paraptosis.
- This plasticity is influenced by metabolic stress, therapeutic pressure, and tumor microenvironmental cues.
- Key molecular factors like ER stress, mitochondrial dysfunction, ion homeostasis, and proteotoxic stress regulate paraptotic outcomes.
Conclusions:
- Paraptotic plasticity represents a novel mechanism of therapeutic resistance in cancer.
- Targeting paraptotic vulnerabilities offers a promising avenue for precision oncology.
- Nanotechnology-based strategies can be developed to overcome resistance in challenging cancers by leveraging paraptotic plasticity.
More Related Videos
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Apoptosis
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy

